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Abstract
Background: Dendritic cells (DCs) are among the first cells to encounter HIV-1 and play important roles in viral
transmission and pathogenesis. Immature DCs allow productive HIV-1 replication and long-term viral dissemination.
The pro-inflammatory factor lipopolysaccharide (LPS) induces DC maturation and enhances the efficiency of DC-
mediated HIV-1 transmission. Type I interferon (IFN) partially inhibits HIV-1 replication and cell-cell transmission in
CD4
+ T cells and macrophages. Tetherin is a type I IFN-inducible restriction factor that blocks HIV-1 release and
modulates CD4
+ T cell-mediated cell-to-cell transmission of HIV-1. However, the role of type I IFN and tetherin in
HIV-1 infection of DCs and DC-mediated viral transmission remains unknown.
Results: We demonstrated that IFN-alpha (IFNa)-induced mature DCs restricted HIV-1 replication and trans-
infection of CD4
+ T cells. Tetherin expression in monocyte-derived immature DCs was undetectable or very low.
High levels of tetherin were transiently expressed in LPS- and IFNa-induced mature DCs, while HIV-1 localized into
distinct patches in these DCs. Knockdown of induced tetherin in LPS- or IFNa-matured DCs modestly enhanced
HIV-1 transmission to CD4
+ T cells, but had no significant effect on wild-type HIV-1 replication in mature DCs.
Intriguingly, we found that HIV-1 replication in immature DCs induced significant tetherin expression in a Nef-
dependent manner.
Conclusions: The restriction of HIV-1 replication and transmission in IFNa-induced mature DCs indicates a potent
anti-HIV-1 response; however, high levels of tetherin induced in mature DCs cannot significantly restrict wild-type
HIV-1 release and DC-mediated HIV-1 transmission. Nef-dependent tetherin induction in HIV-1-infected immature
DCs suggests an innate immune response of DCs to HIV-1 infection.
Background
Dendritic cells (DCs) are professional antigen presenting
cells that bridge innate and adaptive immunity. DCs
play an important role in innate immune recognition
and activation during HIV infection [1,2]. HIV-1 hijacks
DCs to promote viral infection and dissemination [2,3].
Immature dendritic cells (iDCs) in the mucosa are one
of the first cells that encounter HIV-1 during initial
infection [4,5]. Immature DCs allow productive HIV-1
replication and long-term viral dissemination [6-8].
Depending on the stimulus, maturation of DCs has dif-
ferential effects on HIV-1 replication and cell-to-cell
transmission to CD4
+ T cells [6,9-13]. DC-mediated dis-
semination of HIV-1 occurs through the dissociable pro-
cesses of trans- and cis-infection, depending on whether
productive viral infection is initiated in DCs [6]. Produc-
tive HIV-1 infection of DCs can induce DC maturation
and trigger antiviral innate immunity through type I
IFN responses [14].
The major DC subtypes include myeloid DCs and
plasmacytoid DCs (pDC) [2,3]. pDCs produce type I
IFN upon sensing HIV-1 RNA and envelope protein
through Toll-like receptor 7 and other intracellular sen-
sors [15,16]. Type I IFNs are antiviral cytokines
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infection to limit virus dissemination and regulate adap-
tive immune responses to clear the virus and protect
against re-infection [17]. As a type I IFN, IFNa can
inhibit HIV-1 replication in CD4
+ T cells and macro-
phages in vitro [18,19]. A recent study indicated that
IFNa partially inhibits the cell-to-cell transmission of
HIV-1 between CD4
+ T cells [20]. However, it is
unknown whether IFNa can block HIV-1 replication in
DCs or DC-mediated cell-to-cell transmission of HIV-1.
Type I IFNs can induce the expression of HIV-1
restriction factors [21], in particular, APOBEC3 family
proteins [22-24], Trim5a [25] and tetherin (BST-2 or
CD317) [26,27]. Tetherin is a host transmembrane pro-
tein [26,27] and is expressed by a wide-range of human
and animal cells [28,29]. Mouse and human pDCs
[30,31] and human monocyte-derived DCs (MDDCs)
[29] express endogenous tetherin, though its function is
not fully understood. Tetherin has been suggested as a
component of the innate immune responses [32]. It has
been shown that human pDCs express an orphan recep-
tor called immunoglobulin-like transcript 7 (ILT7),
which binds to tetherin and down-regulates the IFN
responses of pDCs [31]. This study suggested that type I
IFN produced by pDCs during viral infection may sti-
mulate neighboring cells to express tetherin, which
interacts with ILT7 on pDCs to down-modulate IFN
and cytokine responses.
Tetherin restricts release of various enveloped viruses,
including a number of retroviruses and several viral pro-
teins function as antagonists of tetherin (reviewed in
[32-36]). Tetherin acts as an HIV-1 restriction factor by
directly tethering HIV-1 virions to the surface of an
HIV-producing cell [27,37], but its effect on incoming
HIV-1 virions during cell-to-cell transmission has not
been documented. The HIV-1 protein Vpu antagonizes
tetherin by causing the degradation [38-41] and the
sequestration of tetherin into a perinuclear compart-
ment away from the site of virus assembly [42]. More-
over, Nef and envelope proteins from some simian
immunodeficiency viruses (SIV) [43-46] and HIV-2
envelope proteins [42,47] function as antagonists of
tetherin in a species-specific manner.
It is unknown whether tetherin plays a role in DC-
mediated HIV-1 infection and transmission. Recent stu-
dies suggest different roles of tetherin in the cell-to-cell
transmission of HIV-1 mediated by CD4
+ T cells
[48-50]. Casartelli et al. reported that tetherin impairs
cell-to-cell transmission of HIV-1 in several cell lines
and primary CD4
+ T cells, and transmission of Vpu-
defective HIV-1 to target CD4
+ T cells is less efficient
than that of wild-type (WT) HIV-1 [49]. By contrast,
Jolly et al. suggested that tetherin can enhance HIV-1
cell-to-cell transmission, and Vpu-defective HIV-1 is
disseminated more efficiently compared with WT HIV-1
in CD4
+ Jurkat T cells [48]. Using tetherin-inducible
Sup-T1 cells, Kuhl et al. recently reported that tetherin
expressed on target cells promotes HIV-1 cell-to-cell
transfer, while tetherin expressed on donor cells inhibits
viral transmission [50]. The discrepancy between these
studies may be due to cell-type-dependent variation in
tetherin expression levels [49,50], which remains to be
confirmed using other primary HIV-1 target cells, such
as DCs or macrophages.
In this study, we investigated the role of IFNa and
tetherin in MDDC-mediated HIV-1 infection and trans-
mission. We demonstrated that IFNa treatment of DCs
restricted DC-mediated HIV-1 infection and transmis-
sion to CD4
+ T cells. We observed that tetherin expres-
sion was transiently upregulated in LPS- or IFNa-
matured DCs and knockdown of induced tetherin mod-
estly enhanced mature DC-mediated HIV-1 transmis-
sion, but had no significant effect on WT HIV-1
replication in mature DCs. Intriguingly, we found that
tetherin was induced by HIV-1 infection of iDCs in a
Nef-dependent manner, suggesting that tetherin upregu-
lation is an innate immune response of DCs to HIV-1
infection.
Results
IFNa induces DC maturation but does not alter the
expression level of HIV-1 receptors
To examine the role of type I IFN in DC-mediated HIV-
1 infection and transmission, human monocyte-derived
iDCs were activated with IFNa to generate mature DCs
(mDC-IFNa) and LPS-induced mature DCs (mDC-LPS)
were used as positive controls. DCs were separately
stained for surface CD86 as a marker of maturation
[6,11,14,51], for the HIV-1 receptors CD4 and CCR5,
and for the HIV-1 attachment factor DC-SIGN (DC-
specific intercellular adhesion molecule-3 grabbing non-
integrin). Maturation of DCs with either LPS or IFNa
caused significant upregulation of CD86 expression on
the cell surface by 6- to 7-fold (Figure 1), indicating that
both mature DC types developed a mature DC pheno-
type. Compared with iDCs, mDC-IFNa did not show
any significant differences in the expression of CD4,
CCR5 or DC-SIGN, while mDC-LPS showed decreased
levels of both CD4 and DC-SIGN (Figure 1). Surface
CCR5 was equally expressed at low levels on all DC
types (Figure 1). Thus, IFNa-induced maturation of
DCs does not significantly affect the expression of HIV-
1 receptors.
IFNa-induced mature DCs do not mediate efficient HIV-1
transmission to CD4
+ T cells
To assess the effect of IFNa on DC-mediated transmis-
sion of HIV-1 to CD4
+ T cells, HIV-1-pulsed mDC-
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Figure 1 IFNa induces DC maturation but does not alter the expression of HIV-1 receptors. iDC, mDC-LPS and mDC-IFNa were stained
for cell surface expression of CD4, CCR5, DC-SIGN and CD86. On each histogram, the filled peaks are the controls of isotype or secondary
antibody alone and the black peaks represent the staining of specific markers. Top and bottom numbers shown in plots are % positive and the
geometric mean values of fluorescence intensity, respectively. Results shown are from DCs from a single donor representative of two
independent experiments on DCs from different donors.
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transmission assays. Single-cycle, R5-tropic luciferase
reporter HIV-1 was used and viral transmission was
determined by measuring luciferase activity in cell
lysates of co-cultures [52]. HIV-1-pulsed DCs alone
were used as a control for background replication.
mDC-LPS showed a 16-fold increase in viral transmis-
sion compared with iDC-mediated moderate transmis-
sion of HIV-1 to CD4
+ T cells (Figure 2A). By contrast,
mDC-IFNa failed to enhance single-cycle HIV-1 trans-
mission to CD4
+ T cells (Figure 2A).
It has been established that there are two distinct
phases in DC-mediated HIV-1 transfer to CD4
+ Tc e l l s
[8]. In the first phase (within 24 hr after infection),
incoming HIV-1 is transferred, whereas in the second
phase (24-72 hr after infection), newly synthesized HIV-
1 can be transmitted [8]. To examine the two-phase
HIV-1 transfer, DC-mediated transmission of replica-
tion-competent R5-tropic HIV-1 NL(AD8) was assessed
by p24 release in supernatants from the co-cultures of
HIV-1-pulsed DCs and Hut/CCR5 cells 2 days later.
Compared with iDC-mediated HIV-1 transmission,
mDC-LPS transmitted HIV-1 to CD4
+ T cells 5-fold
more efficiently, while mDC-IFNa transmitted HIV-1
only 2-fold more efficiently (Figure 2B). Together, these
data indicate that mDC-IFNa do not mediate efficient
HIV-1 transmission to CD4
+ T cells.
Productive HIV-1 replication is restricted in IFNa-induced
mature DCs
To understand the mechanism by which IFNa treat-
ment restricts DC-mediated HIV-1 transmission, the
kinetics of HIV-1 uptake, degradation and replication in
mDC-IFNa were assessed. The reverse transcriptase
inhibitor azidothymidine (AZT) was used to confirm
productive HIV-1 replication in DCs. HIV-1 enters DCs
mainly through endocytosis, but productive HIV-1 infec-
tion of DCs is dependent upon fusion-mediated viral
entry [6,53], therefore, cell-associated p24 can be indica-
tive of either HIV-1 entry pathway in DCs and superna-
tant p24 represents productive viral replication and/or
viral release.
After 2 h incubation of DCs with HIV-1 NL(AD8),
cells were washed extensively, aliquoted and cultured for
up to 7 days. The amount of HIV-1 uptake by DCs was
quantified by measuring the cell-associated p24 at 2 h
post-infection. Compared with iDCs, mDC-LPS and
mDC-IFNa captured 2-fold more HIV-1 (Figure 2C).
Over the time course, iDCs showed increases of both
cell-associated p24 (Figure 2C) and released virus (Fig-
ure 2D), which were efficiently blocked by AZT, consis-
tent with productive HIV-1 replication. The HIV-1
captured by mDC-LPS were degraded (Figure 2C), or
otherwise released into the media over time in a largely
replication independent manner (Figure 2D). HIV-1 in
mDC-IFNa was rapidly degraded, as the cell-associated
p24 reached very low levels at 3 days post-infection
(dpi) (Figure 2C). Low levels of HIV-1 release from
mDC-IFNa was observed at 5 and 7 dpi, which was sig-
nificantly reduced in the presence of AZT (Figure 2D),
indicating delayed viral replication in mDC-IFNa. These
data suggest that IFNa maturation of DCs blocks HIV-1
replication.
Pro-inflammatory stimuli upregulate tetherin expression
in DCs
The above results indicated that HIV-1 replication and
release were restricted in IFNa and LPS-induced mature
DCs relative to iDCs, which might be attributed to the
induction of HIV-1 restriction factors in mature DCs,
such as tetherin. We have reported that pro-inflamma-
tory stimuli (such as LPS) induce DC maturation and
modulate the efficiency of DC-mediated HIV-1 trans-
mission [6]. To examine whether pro-inflammatory sti-
muli upregulate tetherin expression in DCs, DCs from
different donors were treated with IFNa and LPS and
analyzed for tetherin expression on the surface and in
whole cell lysates by flow cytometry and immunoblot-
ting, respectively. Cell surface tetherin in iDCs was low
or undetectable (Figure 3A, donor 1 and 2, respectively),
which correlated well with the levels of tetherin detected
in whole cell lysates (Figure 3B). By contrast, high levels
of surface tetherin were detected in mDC-LPS (Figure
3A), which correlated well with high levels of tetherin
observed in whole cell lysates (Figure 3B). Although the
surface tetherin was low or undetectable in mDC-IFNa,
indicating donor variation of tetherin expression in DCs
(Figure 3A), high levels of tetherin were detected in
whole cell lysates (Figure 3B), suggesting that the
tetherin localization in mDC-IFNa is mainly
intracellular.
To examine whether other pro-inflammatory factors
could induce tetherin expression, iDCs were treated
with tumor necrosis factor alpha (TNF-a), which has
been shown to potently induce DC maturation in our
previous study [6]. TNF-a treatment of MDDCs mod-
estly upregulated tetherin expression (Figure 3C). The
specificity of the tetherin antibody was confirmed using
tetherin-negative 293T cells and tetherin-positive HeLa
cells (Figure 3D). Thus, treatment of DCs with pro-
inflammatory stimuli causesu p r e g u l a t i o no ft e t h e r i n ,
but sub-cellular localization of tetherin can be depen-
dent upon the type of stimulus.
HIV-1 co-localizes with tetherin in mature DCs
Tetherin can show variable sub-cellular localization
[27,28,42,54,55] and the localization of tetherin within a
cell is critical for its antiviral function [54]. To examine
Coleman et al. Retrovirology 2011, 8:26
http://www.retrovirology.com/content/8/1/26
Page 4 of 1810 
100 
1000 
10000 
Mock iDC  mDC-LPS  mDC-IFNα 
L
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
 
(
c
p
s
)
  DC alone 
DC + T cell 
0 
2 
4 
6 
8 
10 
12 
3 5 7 
S
u
p
e
r
n
a
t
a
n
t
 
 
p
2
4
 
(
n
g
/
m
l
)
 
Days post-infection 
iDC 
iDC + AZT 
mDC-LPS 
mDC-LPS + AZT 
mDC-IFNα 
mDC-IFNα + AZT 
A B 
C 
D 
0 
1 
2 
3 
4 
2h 3d   5d 7d 
0 
1 
2 
3 
4 
2h 3d   5d 7d 
Time post-infection 
iDC mDC-LPS  mDC-IFNα 
0 
1 
2 
3 
4 
2h 3d   5d 7d 
C
e
l
l
-
a
s
s
o
c
i
a
t
e
d
 
p
2
4
 
(
n
g
/
m
l
)
 
Medium 
AZT 
0 
1 
2 
3 
iDC mDC-LPS  mDC-IFNα 
S
u
p
e
r
n
a
t
a
n
t
 
p
2
4
 
(
n
g
/
m
l
)
 
DC alone 
DC + T cell 
U.D. 
Figure 2 Transmission and replication of HIV-1 is restricted in mDC-IFNa. Transmission of HIV-1 by DCs was assessed by incubating DCs
with either the single-cycle luciferase reporter HIV-1 or replication-competent HIV-1 NL(AD8) for 2 h, then co-cultured with Hut/CCR5 target cells
for 3 or 2 days, respectively; transmission was assessed by whole-cell luciferase assay or release of p24 in supernatants. (A) mDC-IFNa do not
enhance transmission of the single-cycle luciferase reporter virus to CD4
+ T cells over iDC transmission levels. cps, counts per second. Mock,
mock infected iDCs. Data represent mean ± SEM of three independent experiments performed on DCs from three different donors. U.D.,
undetectable (lower than detection limit). (B) mDC-IFNa do not enhance transmission of HIV-1 NL(AD8) to CD4
+ T cells at 2 dpi (days post-
infection) relative to iDC transmission levels. Graph represents mean data ± SEM from three independent experiments performed with DCs from
three different donors. DCs were infected with WT NL(AD8) and p24 production in the cell lysates (C) or supernatants (D) was monitored after 2
h or 3-7 dpi using a p24 ELISA. AZT was used to assess productive HIV-1 infection. Data are from one experiment and representative of at least
two independent experiments.
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confocal microscopy was used after a 2 h HIV-1 infec-
tion of DCs. GFP-Vpr-tagged replication-competent
HIV-1 (HIV-GFP-Vpr) [56] was used to visualize the
localization of HIV-1 in mature DCs. Previous studies
have shown that in mDC-LPS, HIV-1 strongly concen-
trates in an intense patch [10] and co-localizes with the
tetraspanin CD81 [12,57,58], but not with lysosomal
associated membrane protein-1 (LAMP-1) [58]. There-
fore, DCs were stained for CD81, LAMP-1, and tetherin
to determine the sub-cellular localization of HIV-1.
Consistent with previous reports [12,57,58], HIV-GFP-
Vpr localized into an intense patch with CD81 and did
not co-localize with LAMP-1 in mDC-LPS (Figure 4A),
which was confirmed by the correlation analysis of co-
localization (Figure 4B). Furthermore, the intense patch
of HIV-1 observed in mDC-LPS co-localized with
tetherin (Figure 4A) and the correlation analysis con-
firmed the co-localization (Figure 4B). In mDC-IFNa,
HIV-GFP-Vpr localized into smaller patches near the
plasma membrane (Figure 4C) and showed co-localiza-
tion with CD81 (Figure 4C), with the correlation coeffi-
cient being similar to that observed in mDC-LPS (Figure
4B and 4D). HIV-Vpr-GFP did not co-localize with
LAMP-1 in mDC-IFNa (Figure 4C) and the correlation
coefficient was very low (Figure 4D). The punctate
patches of HIV-1 in mDC-IFNa appeared to localize
with tetherin (Figure 4C and 4D). These data indicate
that in mDC-IFNa and mDC-LPS, HIV-1 localizes into
distinct patches that co-localize with CD81 and tetherin
but not with LAMP-1. These results suggest that LPS-
and IFNa-induced tetherin expression may affect HIV-1
trafficking and transmission in mature DCs.
Tetherin knockdown in mature DCs modestly enhances
HIV-1 transmission to CD4
+ T cells
To examine the role of tetherin in mature DC-mediated
HIV-1 transmission to CD4
+ T cells, tetherin expression
in mature DCs was silenced with specific siRNA. To
achieve efficient knockdown, iDCs were nucleofected
with tetherin-specific or control siRNA and matured
with LPS or IFNa. Analyses of tetherin expression at 2
days post nucleofection confirmed efficient knockdown
of surface tetherin in mDC-LPS (Figure 5A) and total
tetherin in mDC-IFNa (Figure 5C). To assess DC-
mediated HIV-1 transmission, tetherin-silenced DCs
were pulsed with the single-cycle luciferase reporter
HIV-1 and co-cultured with the target Hut/CCR5 cells.
Tetherin-silenced mDC-LPS and mDC-IFNa showed a
modest 30-50% increase over the scramble siRNA con-
trols in transmission of HIV-1 to Hut/CCR5 cells (Fig-
ure 5B and 5D), though the differences were statistically
significant (P < 0.01). These data suggest that high levels
of tetherin induced in mature DCs can modestly impair
DC-mediated transmission of HIV-1 to CD4
+ T cells.
Induced tetherin in mature DCs has different effects on
WT and Vpu-deleted HIV-1 replication and DC-mediated
HIV-1 transmission to CD4
+ T cells
To further examine the role of induced tetherin in repli-
cation-competent HIV-1 infection and transmission
mediated by DCs, we assessed the effect of tetherin
knockdown on the release of WT and Vpu-deleted
(ΔVpu) HIV-1 from infected mature DCs and on DC-
mediated HIV-1 transmission to Hut/CCR5 cells. Effi-
cient tetherin knockdown was achieved in mDC-LPS
and mDC-IFNa (Figure 5A,C and data not shown).
Tetherin-silenced mature DCs were infected with WT
NL(AD8) or ΔVpu NL(AD8) and HIV-1 p24 in the
supernatants was assessed at 5 dpi, which was generally
the peak of HIV-1 replication in iDCs (Figure 2D).
Tetherin knockdown in mDC-LPS had no significant
effect on the release of WT HIV-1, while the release of
ΔVpu HIV-1 was inhibited 2-fold upon tetherin knock-
d o w n( F i g u r e6 A ) .B yc o n t r a s t ,t h er e l e a s eo fW Ta n d
ΔVpu HIV-1 from mDC-IFNa was enhanced by 38%
and 2-fold upon tetherin knockdown, respectively (Fig-
ure 6B). HIV-1 infections of tetherin-silenced mature
DCs were performed three times with different donors’
cells and there was no statistically significant difference
in WT HIV-1 release. Thus, induced tetherin expression
in mature DCs does not play a major role in restriction
of WT HIV-1 replication.
We next assessed the effect of tetherin knockdown on
WT and ΔVpu HIV-1 transmission from mature DCs to
CD4
+ T cells. Upon tetherin knockdown in mDC-LPS,
transmission of WT and ΔVpu HIV-1 was inhibited by
25% and 2-fold, respectively (Figure 6C). By contrast,
upon tetherin knockdown in mDC-IFNa,t r a n s m i s s i o n
of WT HIV-1 was enhanced 2-fold, while transmission
of ΔVpu HIV-1 was not significantly affected (Figure
6D). As a background control of HIV-1 transmission
assays, there were low levels of HIV-1 release from
HIV-1-infected DC alone samples (Figure 6C and 6D).
Together, these results suggest that induced tetherin in
mDC-LPS and mDC-IFNa has different effects on
ΔVpu HIV-1 replication and transmission, which might
be due to the distinct tetherin localization in these cells.
HIV-1 replication in iDCs upregulates tetherin
independently of Vpu
To examine the role of Vpu and tetherin interactions in
HIV-1 infection of DCs, DCs were separately infected
with WT NL(AD8) and ΔVpu HIV-1, and viral replica-
tion was assessed by p24 production in the supernatants
over a time course. There was no significant defect in
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when Vpu was absent (Figure 7A). A 40% decrease of
p24 release was observed from mDC-LPS at 7 dpi in the
absence of Vpu (Figure 7A), suggesting that Vpu could
partially counteract tetherin-mediated restriction of
HIV-1 release.
HIV-1 infection of certain cell types can modulate
tetherin surface expression [28,59,60]. However, no
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mDC- IFNa. (D) Pearson’s correlation coefficient analysis of mDC-IFNa images. Numbers on graphic bars indicate the number of cells analyzed.
Data presented are the mean ± SEM. Scale bars are 10 μm.
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tetherin expression in DCs. To assess whether HIV-1
infection affects the level of tetherin expression in DCs,
iDCs, mDC-LPS and mDC-IFNa were separately
infected with WT NL(AD8) and ΔVpu, and the expres-
sion of tetherin and HIV-1 Gag in DCs at 2 h and 3-7
days post-infection were assessed by immunoblotting.
The p24 bands detected in all DC types at 2 h post-
infection were from input HIV-1 associated with DCs
(Figure 7B-D), and mDC-LPS efficiently endocytosed
HIV-1 (Figure 7C). In iDCs infected with WT and
ΔVpu HIV-1, there was a clear emergence of Gag p55
and p24, indicative of virus replication, and there was a
corresponding induction of tetherin expression at 3 dpi
(Figure 7B). Tetherin expression in HIV-1 infected iDCs
appeared to diminish over time in a Vpu-independent
manner (Figure 7B). These results suggest that HIV-1
infection of iDCs induces significant tetherin expression
despite Vpu expression. In mDC-LPS and mDC-IFNa,
high levels of DC maturation-induced tetherin were
detected at 2 h post-infection, but the levels of tetherin
in the mock-infected controls diminished after 3 dpi
(Figure 7C and 7D). HIV-1-infected mature DCs showed
consistently higher tetherin expression than mock
infected controls, which also diminished over time in a
Vpu-independent manner (Figure 7C and 7D). Notably,
in mDC-IFNa, when low levels of HIV-1 productive
replication were observed at 7 dpi (Figure 2D and 7D),
there was a slight increase in tetherin expression (Figure
7D), suggesting that HIV-1 replication can induce
tetherin expression in DCs. Furthermore, we compared
cell surface levels of tetherin expression in WT and
ΔVpu HIV-1 infected iDCs. Flow cytometry analysis
confirmed that WT HIV-1 and ΔVpu-infected iDC
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Page 9 of 18similarly upregulated tetherin surface expression at 3
and 5 dpi compared with mock-infected cells (Figure
7E).
HIV-1 replication in iDCs upregulates tetherin in a Nef-
dependent manner
A previous study suggested that the upregulation of
tetherin surface expression by HIV-1 infection in macro-
phages appears to be Nef-dependent [59]. To investigate
whether tetherin induction by HIV-1 in DCs was depen-
dent on Nef synthesized during viral infection, iDCs
were separately infected with WT NL(AD8) and Nef-
deleted mutant (ΔN e f )i nt h ep r e s e n c eo ra b s e n c eo f
AZT. The expression of tetherin and HIV-1 Gag in DCs
was assessed by immunoblotting at 5 dpi, which repre-
sented the peak of HIV-1 replication in iDCs (Figure
2D). WT HIV-1 infection of iDCs induced tetherin
expression at 5 dpi, which could be abolished by AZT
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Page 11 of 18treatment (Figure 8A). The ΔNef HIV-1 mutant failed to
induce tetherin, despite similar Gag production relative
to WT HIV-1 infection (Figure 8A). Furthermore, flow
cytometry analysis of tetherin expression in infected
DCs confirmed that WT HIV-1 but not ΔNef mutant
induced tetherin surface expression (Figure 8B). Thus,
HIV-1 replication in iDCs induces transient upregula-
tion of tetherin expression due to the production of Nef.
Nef enhances the expression levels of mRNA encoding
IFN-induced protein with tetratricopeptide repeats 1 (IFIT-
1) in HIV-1-infected iDCs
To explore the underlying mechanisms of Nef-depen-
dent tetherin induction in HIV-1-infected iDCs, we
quantified mRNA levels of IFIT-1, an IFN stimulated
gene (ISG), in WT HIV-1 NL(AD8) or ΔNef-infected
iDCs using real-time RT-PCR. Compared with mock
infection, WT and ΔNef HIV-1 infections in iDCs
resulted in a 5-fold increase of IFIT1 mRNA levels at 6
hr post-infection (Figure 9). At 16 and 48 hr post-infec-
tion, WT HIV-1 increased IFIT1 mRNA levels in
infected iDCs 44- and 40-fold, respectively, relative to
mock infection. By contrast, ΔNef HIV-1 infection in
iDCs increased IFIT1 mRNA levels 13- and 27-fold at
16 and 48 hr post-infection, respectively, compared with
mock infection (Figure 9). These data suggest that HIV-
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Figure 8 HIV-1 replication in iDCs upregulates tetherin in a Nef-dependent manner. (A) Cell lysates from iDCs infected with WT NL(AD8),
NL(AD8)ΔNef with (+) or without (-) AZT or mock infected were evaluated at 5 dpi for the expression of HIV-1 Gag (p55 and p24), tetherin and
GAPDH by immunoblotting. (B) Flow cytometry analysis of surface tetherin expression in infected DCs at 5 dpi. M, Mock infection; WT, wild-type
NL(AD8); ΔNef, NL(AD8)ΔNef. One representative experiment out of three is shown.
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Page 12 of 181 infection of iDCs induces ISG mRNA expression as an
innate immune response, and that Nef plays an impor-
tant role in this process.
Discussion
Previous studies indicated that IFNa treatment par-
tially inhibits post-entry HIV-1 replication and cell-to-
c e l lt r a n s m i s s i o ni nC D 4
+ T cells and macrophages
[18-20], suggesting type I IFN-mediated anti-HIV
responses. Compared with iDCs, mDC-LPS do not
support productive HIV-1 replication, but mediate
highly efficient cell-to-cell transmission [2,6,9,11]. To
better understand the innate immune response of DCs
to HIV-1 infection, we investigated the effect of IFNa
on HIV-1 replication and cell-to-cell transmission
using primary human DCs. We found that DC-
mediated HIV-1 transmission and viral replication
were impaired in mDC-IFNa.I F N a induced DC
maturation but did not affect overall expression levels
of HIV-1 receptors and the attachment factor DC-
SIGN, suggesting that mDC-IFNa can mediate HIV-1
binding and entry. Compared with mDC-LPS, mDC-
IFNa-mediated transmission of HIV-1 to CD4
+ Tc e l l s
was significantly lower. Our data suggest that IFNa
treatment of DCs induces an antiviral response to
block HIV-1 replication and cell-to-cell transmission.
IFNa is a major inducer of tetherin expression [27,61],
and other pathogenic stimuli have been suggested to sti-
mulate tetherin expression as part of the innate immune
response [32]. We thus evaluated any link between
tetherin and the inhibition of HIV-1 replication and
cell-to-cell transmission in DCs by assessing the levels
of tetherin expression in iDCs and mature DCs. We
observed that iDCs were extremely low or negative for
tetherin expression, while mDC-LPS showed high levels
of tetherin expression at the cell membrane. By contrast,
mDC-IFNa were negative, or expressed very low levels
of surface tetherin despite high levels of whole cell
tetherin expression, indicating that IFNa-induced
tetherin is mainly confined to the intracellular compart-
ment in mDC-IFNa. Given the different expression
levels and apparent sub-cellular localization patterns of
tetherin within DCs, we therefore investigated any link
between the high levels of tetherin induced in mature
DCs and the HIV-1 replication and cell-to-cell transmis-
sion phenotypes observed in these cells.
Tetherin localization and co-localization with HIV-1 is
vital to its restriction function, as it must tether the
newly formed HIV-1 virions to the cell membrane
[37,49,54,55,61]. The localization of HIV-1 in mDC-
IFNa may contribute to restricted HIV-1 transmission
to CD4
+ T cells. HIV-1 and CD81 strongly co-localized
in mDC-LPS, with clear evidence of concentration of
CD81 at the site of HIV-1 binding, as expected
[12,57,58]. Co-localization of HIV-1 and CD81 was also
observed in mDC-IFNa, but there was no evidence of a
concentration of CD81 at the sites of HIV-1 binding,
suggesting that the localization of HIV-1 is distinct from
that observed in mDC-LPS. The lack of co-localization
between HIV-1 and LAMP-1 in mDC-LPS and mDC-
IFNa indicates that HIV-1 did not traffic to the lyso-
some for degradation in either cell type at 2 h post-
infection. In both mDC-LPS and mDC-IFNa, co-locali-
zation of tetherin and HIV-GFP-Vpr was observed,
which raises questions about whether tetherin affects
incoming HIV-1 captured by mature DCs.
We sought to investigate the direct effect of tetherin
on the replication and DC-mediated transmission of
H I V - 1b ys i l e n c i n gt e t h e r i ni nm D C - L P Sa n dm D C -
IFNa. Recent studies of the tetherin function in HIV-1
cell-to-cell spread have focused on viral transmission
from infected CD4
+ T cells to uninfected cells [48-50].
However, in DC-mediated HIV-1 transmission, DC-cap-
tured virus is concentrated at, or near, the cell surface
and can be transmitted to CD4
+ T cells without produc-
tive replication in DCs [2,6,9-12,62]. Furthermore, the
major role of tetherin is to prevent the release of fully
formed HIV-1 virions from the cell surface [27,37,55],
rather than affecting incoming virions. In a single-cycle
HIV-1 transmission assay, tetherin knockdown in mDC-
LPS and mDC-IFNa resulted in a modest increase of
viral transmission to CD4
+ T cells, suggesting that high
levels of induced tetherin in mature DCs may partially
impair DC-mediated transmission of incoming HIV-1 to
CD4
+ T cells. It is possible that tetherin siRNA may
have potential off-target effect, which should be consid-
ered in transient tetherin downregulation in primary
DCs. Recent studies indicated that tetherin knockdown
in CD4
+ T cells reduces the formation of the virological
synapse and HIV-1 cell-to-cell transmission [48,49].
Whether tetherin knockdown affects the formation of
the virological synapse between DCs and CD4
+ T cells
remains to be established.
A recent study indicated that tetherin expressed on
target Sup-T1 cells can promote HIV-1 cell-cell trans-
mission [50]. In this study, we focused on the role of
tetherin in donor DCs and used Hut/CCR5 T cells as
targets in DC-mediated HIV-1 transmission assays. Hut/
CCR5 cells express high levels of endogenous tetherin
(data not shown), while primary human CD4
+ T cells
express variable levels of tetherin [49,63]. Using Hut/
CCR5 cells avoided donor variations of tetherin expres-
sion in primary CD4
+ T cells. However, it remains to be
investigated whether tetherin expressed in CD4
+ T cell
targets affects DC-mediated HIV-1 transfer.
Tetherin inhibits HIV-1 release from cells, and its
function is antagonized by Vpu [27,37]. We investigated
HIV-1 replication and release in mature DCs using
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effect of tetherin knockdown on HIV-1 release from
mature DCs appears to be dependent upon the matura-
tion stimulus used and on the expression of Vpu by the
virus. Our data demonstrate that tetherin expression
alone is not responsible for restriction of WT HIV-1
replication in mature DCs. Indeed, previous work has
identified other mechanisms responsible for post-entry
restriction of HIV-1 replication in mDC-LPS [6]. The
restriction of HIV-1 replication in mDC-IFNa may be
due to multiple restriction factors. For example, APO-
BEC3G can block HIV-1 infection in DCs, and its
expression is upregulated by IFNa and LPS [24,64].
In iDCs, which do not express high levels of endogen-
ous tetherin, there was a significant increase in tetherin
expression in response to the infection with WT and
ΔVpu HIV-1. This is consistent with earlier studies that
endogenous tetherin in macrophages can be upregulated
by HIV-1 infection [59]. When mDC-LPS and mDC-
IFNa were infected with WT or ΔVpu HIV-1, tetherin
expression was maintained longer than that in mock-
infected controls, which is presumably due to stabiliza-
tion of tetherin or replenishment by tetherin induction.
The maintenance of tetherin expression within mature
DCs does not appear to be affected by Vpu expression.
Upregulation of surface tetherin in macrophages by
HIV-1 infection appears to be induced by Nef [59], and
HIV-1 replication in a human CD4
+ cell line causes
tetherin induction after an initial down-modulation of
tetherin [28]. Thus, we investigated the role of both
HIV-1 replication and Nef protein in the transient
induction of tetherin in iDCs. AZT treatment and dele-
tion of Nef blocked the HIV-1-mediated tetherin upre-
gulation in iDCs. These data suggest a role of newly
synthesized Nef in the transient upregulation of tetherin
in iDCs. HIV-1 Nef can cause induction of pro-inflam-
matory cytokines from human DCs and macrophages
[65,66], so it is possible that these cytokines act in an
autocrine manner to induce transient tetherin expres-
s i o ni nD C sa sp a r to fa ni n n a t ei m m u n er e s p o n s et o
HIV-1 infection. Moreover, an increase in cellular con-
tent of tetherin may reflect its stabilization or a slow
turn-over upon HIV-1 infection and expression of Nef.
The mechanisms by which Nef induces tetherin expres-
sion in DCs remain to be elucidated.
Of note, a recent study indicated that HIV-1 infection
of MDDCs undermines the IFN induction pathway via
interferon regulatory factor 1 (IRF1) and blocks type I
IFN production, although HIV-1 infection in DCs
induces a subset of ISGs [67]. In agreement with this
report, we were not able to detect the release of IFNa
or IFNb in the supernatants from HIV-1-infected iDCs
at 1 to 5 dpi despite significant increases of IFIT-1
mRNA expression.
It is unclear as to why HIV-1 has not evolved a
mechanism to block Nef-dependent induction of
tetherin in DCs in addition to expressing Vpu as an
antagonist of tetherin. Given the apparent transient nat-
ure of the Nef-induced tetherin expression in DCs, it is
possible that as the tetherin level naturally diminishes
over time, it does not affect HIV-1 release at time points
of significance. HIV-1-induced tetherin expression also
has the potential to ensure that HIV-1 remains in close
association with the cell. In the case of DCs, this may
allow HIV-1 to stay in close association with the cells
during trafficking to the lymph node and subsequent
transmission to CD4
+ T cells at late time points, as is
suggested to occur in vivo [2,5].
In summary, we have investigated the role of IFNa
and tetherin in DC-mediated HIV-1 infection and trans-
mission. Our data suggest that tetherin is not a major
restriction factor for WT HIV-1 replication in DCs or
DC-mediated cell-to-cell transmission of HIV-1 to CD4
+
T cells. Interestingly, we found that HIV-1 infection of
iDCs induces Nef-dependent tetherin expression, sug-
gesting an intrinsic antiviral mechanism in DCs trig-
gered by productive HIV-1 infection and the pathogenic
factor Nef. Further studies of this mechanism in DCs
will provide a better understanding of the innate
immune response against HIV-1 infection.
Conclusions
The restriction of HIV-1 replication and transmission in
IFNa-induced mature DCs indicates a potent anti-HIV-
1 response; however, high levels of tetherin induced in
mature DCs cannot significantly restrict WT HIV-1
release and DC-mediated HIV-1 transmission. Nef-
dependent tetherin induction in HIV-1-infected imma-
ture DCs suggests an innate immune response of DCs
to HIV-1 infection.
Methods
Plasmids and HIV-1 stocks
Single-cycle luciferase reporter HIV-1 was generated by
co-transfection of HEK293T cells with pLai3ΔenvLuc2
(a kind gift from Michael Emerman) and an expression
plasmid for R5-tropic HIV-1JRFL envelope protein as
described [68]. The infectivity of viral stocks was
assessed by limiting dilution in GHOST/R5 cells as
described [69]. R5-tropic, replication-competent HIV-1
strain NL(AD8) and its derivates, NL(AD8)ΔVpu, and
NL(AD8)ΔNef were generated by transfection of
HEK293T cells separately with pNL(AD8) [70] (a kind
gift from Eric Freed), pNL(AD8)ΔVpu [71] (a kind gift
from Klaus Strebel) or pNL(AD8)ΔNef [72] (a kind gift
from Olivier Schwartz) as described [68]. HIV-GFP-Vpr
was generated by co-transfection of HEK293T cells with
pNL(AD8) and a Vpr-GFP expression vector pGFP-Vpr
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Gag p24 concentrations of viral stocks were measured
using an enzyme-linked immunosorbent assay (ELISA;
The AIDS Vaccine Program, SAIC, Frederick, MD).
Cell culture
Monocytes were isolated from buffy coats (American
Red Cross Blood Service, Columbus, Ohio) by Histopa-
que and Percoll (Sigma-Aldrich) gradient centrifuga-
tion as described [68]. All DCs utilized in this study
were in culture for 7 days post-monocyte isolation.
iDCs were generated by incubation of the monocytes
in the presence of interleukin 4 and granulocyte-
macrophage colony stimulating factor for 7 days as
described [68]. LPS-induced mature DCs (mDC-LPS)
were generated by addition of 10 ng/ml LPS (Escheri-
chia coli strain O55:B5; Sigma-Aldrich) to day 5 iDCs
and subsequently cultured for an additional 2 days.
IFN-a matured DCs (mDC-IFN-a) were generated by
addition of 2,000 IU/ml of recombinant IFN-a-A/D
(Sigma-Aldrich) to day 6 iDCs and subsequently cul-
tured for an additional one day. iDCs were treated
with TNF-a (PeproTech) at the indicated concentra-
t i o n sa n dc u l t u r e df o r2 4h rb e f o r ei m m u n o b l o t t i n g
analysis of tetherin expression. HEK293T and HeLa
cell lines were maintained in DMEM supplemented
with 10% fetal calf serum, L-glutamine and penicillin
and streptomycin. Hut/CCR5 cells (kind gift from
Vineet KewalRamani) were grown in selective media as
previously described [52].
Flow cytometry analysis of surface marker expression
DCs were stained with phycoerythrin (PE)- or fluores-
cein isothiocyanate (FITC)-conjugated antibodies to
CD4 (clone number S3.5; Invitrogen), DC-specific inter-
cellular adhesion molecule-3-grabbing non-integrin
(DC-SIGN, clone number 120507; R&D Systems) or
CD86 (clone number BU63; Invitrogen). Negative con-
trols were antibodies matched for isotype and fluores-
cent conjugates: mouse IgG2a (PE conjugate; BD
Biosciences), mouse IgG2 (FITC conjugate; BD Bios-
ciences) or mouse IgG1 (FITC conjugate; Invitrogen).
For CCR5 staining, DCs were stained with a purified
antibody to CCR5 (clone number 3A9; BD Biosciences),
followed by a FITC-conjugated goat anti-mouse second-
ary antibody (Caltag) as described [53]. Cells were
stained for surface tetherin expression using a rabbit
serum against tetherin [55] in conjunction with a
PE-conjugated goat anti-rabbit Fab fragment (BD Bios-
ciences). Stained cells were analyzed on a Guava Easy-
Cyte Mini (Millipore) flow cytometer and data were
processed using the FlowJo software (Tree Star). Statis-
tics for percentage positive cells were established by set-
ting up a histogram gate equivalent to 1% on the
relevant negative control cells and utilizing the same
gate on stained cells.
Immunoblotting
Cell lysates were prepared using a Cell Lysis Buffer (Cell
Signaling) supplemented with the Protease Inhibitor
Cocktail (Sigma-Aldrich) according to the manufac-
turer’s instructions. Following protein quantification
using a BCA kit (Pierce), 10 μg of each lysate was run
on an 8%:13% SDS-polyacrylamide gel or a 12.5% Criter-
ion pre-cast gel (Bio-Rad) and transferred to polyvinyli-
dine fluoride membrane (Millipore) using an
Electrophoretic Transfer Cell or Semi-Dry Elecrophore-
tic Transfer Cell (Bio-Rad). Blots were stained with
either the anti-tetherin rabbit serum [55], an anti-HIV-1
p24 (clone number 24-2, the NIH AIDS Research and
Reference Reagent Program), or an anti-GAPDH (Imge-
nex), followed by a relevant horseradish peroxidase-con-
jugated secondary (anti-rabbit or anti-mouse, Promega).
Blots were stripped for subsequent probes using Wes-
tern Blot Stripping Buffer (Thermo Scientific) according
to the manufacturer’s instructions. Blots were visualized
using West Pico chemiluminescent substrates (Thermo
Scientific) and a FujiQuick imager (FujiFilm).
Confocal microscopy
DCs (2 × 10
5) were pulsed with HIV-Vpr-GFP (20 ng of
p24) for 2 h, then washed once with phosphate buffer
saline (PBS) and prepared for confocal microscopy [57].
Cells were adhered to a poly-L-lysine coated slide, fixed
and permeabilized as described [68]. Cells were labeled
using antibodies to CD86 (clone number IT2.2, BD
Pharmingen), LAMP-1 (clone number H4A3, BD Phar-
mingen), and tetherin followed by Alexi-Fluor-568 con-
jugated anti-mouse or anti-rabbit secondary antibodies
(both from Invitrogen). Slides were sealed with Gold
anti-fade reagent (Invitrogen) and analyzed on an
FV100-Spectral or FV100-Filter confocal microscope
(Olympus). Images were processed and co-localization
analyses were performed using the FV10-ASW 2.0
Viewer (Olympus).
siRNA knockdown of tetherin in matured DCs
It has been shown that iDCs are far more receptive to
nucleofection than mDC-LPS [6]. To efficiently knock-
down tetherin in mature DCs, iDCs were nucleofected
with a specific siRNA pool against tetherin and subse-
quently matured with LPS as described [62]. Amaxa
nucleofector and a DC-specific nucleofection kit (Lonza)
were used to nucleofect iDCs, according to the manu-
facturer’si n s t r u c t i o n .i D C s( 2×1 0
6) were nucleofected
with 3 μg of a nonspecific siRNA control or a specific
siRNA (siGENOME SMARTPOOL) targeting BST-2
(Dharmacon). Nucleofected cells were subsequently
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vated with 100 ng/ml of LPS or 2,000 U/ml of IFN-a
for 1 day to generate mature DCs.
HIV-1 infection and transmission assays
DCs (2 × 10
5) at day 7 of culture were challenged with
HIV-1 (20 ng of p24) for 2 h as described [11]. HIV-1
infected DCs were washed once with PBS to remove
unbound virions and subsequently cultured for indicated
times. Cell lysates and supernatants were collected at
indicated times for assessment of p24 concentration by
ELISA. Samples were lysed using 1% Triton X-100 for 1
ha t3 7 ° C .W h e r ei n d i c a t e d , cells were treated with 1
μM of AZT (NIH AIDS Research and Reference
Reagent Program) for the duration of HIV-1 infection
and subsequent culture. DC-mediated HIV-1 transmis-
sion assays (4 ng of p24 equivalent HIV-1 input) were
performed using the Hut/CCR5 cells as target cells as
described [6].
RT-PCR quantification of IFIT-1 expression in HIV-1-
infected iDCs
iDCs (2.5 × 10
6) were mock infected or infected with
HIV-1 NLAD8 or NLAD8ΔN e ff o r2h r ,w a s h e dw i t h
PBS and subsequently cultured for 6, 16 and 48 hr. At
each indicated time point, cells were harvested and total
cellular RNA was extracted using the RNeasy Mini kit
(Qiagen) and treated with RNase-free DNase (Ambion).
cDNA was synthesized using the SuperScript III first-
strand synthesis system (Invitrogen) according to the
manufacturer’s instruction. The relative levels of cDNA
were assessed for spliced glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) using specific primers (forward,
5’-GGA AGG TGA AGG TCG GAG TCA ACG G-3’;
reverse, 5’-CTG TTG TCA TAC TTC TCA TGG TTC
AC-3’), and for IFIT-1 using specific primers (forward,
5’-CAA CCA TGA GTA CAA ATG GTG-3’;r e v e r s e ,
5’-CTC ACA TTT GCT TGG TTG TC-3’). Real-time
PCR was performed with the iQ SYBER Green kit (Bio-
Rad) using the CFX96 real-time system as previously
described [6].
Statistical analysis
Data were analyzed using a two-way ANOVA test and
Bonferroni post-test. Statistical significance was defined
as P < 0.05.
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